Simplify Asset Management »

Eyepoint Pharmaceuticals shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 90k 14.24
2025-06-30 $748k 80k 9.41
2025-03-31 $478k 88k 5.42

More positions owned by Simplify Asset Management

Simplify Exchange Traded Fun Government Money (SBIL)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Multi Qis Altern (QIS)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Simplify Exchange Traded Fun Us Eqt Pls Upsid (SPUC)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Natl Muni Bd Etf (NMB)
Simplify Exchange Traded Fun Next Intangible (NXTI)
Simplify Exchange Traded Fun Target 15 Distri (XV)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Simplify Exchange Traded Fun Currency Strateg (FOXY)

View all positions for Simplify Asset Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
Franklin Resources
BlackRock
Vanguard Group
Federated Investors
TCG Crossover Management
Citadel Advisors
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
OrbiMed Advisors
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals